The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 354:632-634 February 9, 2006 Number 6
NextNext

Proven and Unproven Therapy for Benign Prostatic Hyperplasia
Robert S. DiPaola, M.D., and Ronald A. Morton, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Bent, S.
-PubMed Citation

The desire to take medicine is one feature which distinguishes man, the animal, from his fellow creatures.

— William Osler1

The Food and Drug Administration (FDA) is the regulatory body charged with assessing the basic and clinical science underlying the introduction of new drugs into clinical practice and evaluating the efficacy and safety of new pharmaceutical agents, usually on the basis of data from phase 3 randomized trials. Almost always, the FDA initially limits the use of drugs it approves by requiring them to be prescribed by a physician.

In contrast, herbs and other botanical products, which are defined as . . . [Full Text of this Article]


Source Information

From the Departments of Medicine (R.S.D.) and Surgery (R.A.M.), Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.